Phase I/II trial of preoperative oxaliplatin, docetaxel, capecitabine, and radiation for localized esophageal cancer

被引：0
|
作者：
Meluch, A. A.
Spigel, D. R.
Greco, F. A.
Yardley, D. A.
Burris, H. A., III
Farley, C.
Peyton, J. D.
Shipley, D. L.
Steis, R. G.
Hainsworth, J. D.
机构：
[1] Sarah Cannon Res Inst, Nashville, TN USA
[2] Tennessee Oncol, Nashville, TN USA
[3] Atlanta Canc Care, Roswell, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4595
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A prospective phase I/II trial of capecitabine with escalating mitomycin C and oxaliplatin in patients with advanced or metastatic esophageal carcinoma
    Nehls, O.
    Klump, B.
    Kreth, F.
    Schick, D.
    Koppenhoefer, U.
    Lauer, U. M.
    Gregor, M.
    Bitzer, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [22] Phase I-II trial of concurrent capecitabine and oxaliplatin with preoperative intensity-modulated radiotherapy in patients with locally advanced rectal cancer
    Javier Aristu, Jose
    Arbea, Leire
    Rodriguez, Javier
    Luis Hernandez-Lizoain, Jose
    Javier Sola, Jesus
    Moreno, Marta
    Diego Azcona, Juan
    Antonio Diaz-Gonzalez, Juan
    Miguel Garcia-Foncillas, Jesus
    Martinez-Monge, Rafael
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (03): : 748 - 755
  • [23] A phase I/II trial of docetaxel (D) and oxaliplatin (O) in patients with advanced gastric cancer (AGC)
    Park, Y.
    Kim, K.
    Choi, M.
    Hong, J.
    Lee, E.
    Park, M.
    Kim, H.
    Lee, Y.
    Park, J.
    Lim, H.
    Kang, W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] A phase I/II study of docetaxel /S-1 with radiation for esophageal cancer patients
    Hirai, T.
    Matsumoto, H.
    Hirabayashi, Y.
    Urakami, A.
    Yamashita, K.
    Hiratsuka, J.
    Imajyo, Y.
    Tsunoda, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] A phase II trial of Neoadjuvant docetaxel and capecitabine for locally advanced breast cancer
    Lebowitz, PF
    Eng-Wong, J
    Swain, SM
    Berman, A
    Merino, MJ
    Chow, CK
    Venzon, D
    Zia, F
    Danforth, D
    Liu, E
    Zujewski, J
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (20) : 6764 - 6769
  • [26] Phase II trial of docetaxel/capecitabine in hormone-refractory prostate cancer
    Kolodziej, Michael
    Neubauer, Marcus A.
    Rousey, Steven R.
    Pluenneke, Robert E.
    Perrine, George
    Mull, Stephanie
    Boehm, Kristi A.
    Ilegbodu, Des
    Asmar, Lina
    [J]. CLINICAL GENITOURINARY CANCER, 2006, 5 (02) : 155 - 161
  • [27] FINAL SAFETY AND EFFICACY RESULTS OF A PHASE II TRIAL OF BEVACIZUMAB, CAPECITABINE, OXALIPLATIN, RADIATION RECTAL CANCER TRIAL (A-CORRECT)
    Kennecke, H.
    Berry, S.
    Wong, R.
    Zhou, C.
    Tankel, K.
    Easaw, J.
    Rao, S.
    Post, J.
    Hay, J.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 211 - 211
  • [28] A phase II trial of preoperative chemoradiation therapy plus bevacizumab and erlotinib in the treatment of localized esophageal cancer
    Meluch, A. A.
    Bendell, J. C.
    Peyton, J. D.
    Rudolph, P.
    Rubin, M. S.
    Webb, C. D.
    Greco, F. A.
    Infante, J. R.
    Burris, H. A., III
    Hainsworth, J. D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] A phase II study of oxaliplatin, docetaxel, and capecitabine in advanced carcinoma of the esophagus and stomach
    Anderson, E. J.
    Safran, H.
    Miner, T.
    Shipley, J.
    Mcnulty, B.
    Akerman, P.
    Saba, N.
    Jean, M.
    Millis, R.
    Sio, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] A phase I/II trial of docetaxel, capecitabine, and cisplatin as a first line chemotherapy for advanced gastric cancer.
    Kang, YK
    Kim, TW
    Chang, HM
    Ryu, MH
    Yook, JH
    Oh, ST
    Kim, BS
    Lee, JS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 329S - 329S
12345